Core Viewpoint - The China Securities Regulatory Commission (CSRC) has requested additional information from Kefu Medical regarding its overseas listing application, focusing on compliance with regulations and operational details of its subsidiaries [1][2]. Group 1: Regulatory Compliance - CSRC requires Kefu Medical to clarify whether its domestic subsidiaries fall under the prohibitions outlined in the "Interim Measures for the Administration of Overseas Issuance and Listing of Domestic Enterprises" [1] - The company must provide details on its subsidiaries' business scope, particularly in advertising and internet information services, and confirm whether they have obtained the necessary licenses [1]. Group 2: Company Overview - Kefu Medical is one of the largest home medical device companies in China, ranking second in sales among all home medical device enterprises according to Frost & Sullivan [2]. - The company has expanded its global presence, covering over 60 countries and regions across Asia, Africa, Europe, and America, attracting a growing loyal customer base [2]. - As of June 30, 2025, Kefu Medical operates 738 self-owned stores in China, with 689 being "Jianer Hearing" service centers, providing professional hearing testing services and various quality hearing aid products [2].
可孚医疗拟港股IPO 中国证监会要求说明境内子公司是否存在相关规定的不得境外发行上市情形